The Microbiome in Infant Health and Disease

The Microbiome in Infant Health and Disease

The objective of this session is to review the role of early life exposures in altering the infant gut microbiome and the impact on disease risk, including obesity and allergic diseases.

  • Release Date: December 8, 2021
  • SKU FNCE21356
Member Price
$24.00
Nonmember Price
$54.00

Student Member Price: $10.00

There is increasing evidence that implicates gastrointestinal microbiota as a critical player in the development of diseases in children. Epidemiological studies suggest that early life exposures can alter the gut microbial composition such that differential composition and colonization may influence disease risk. The objective of this session is to review the role of early life exposures in altering the infant gut microbiome and the impact on disease risk, including obesity and allergic diseases.

Planned with the Pediatric Nutrition DPG

CPE Level: Level 2 (intermediate knowledge/experience)
CPEU: 1.0

Performance Indicators

  • 10.1.2 Conducts nutrition screening to identify client/patient risks and levels of criticality, and to direct services.
  • 6.2.3 Analyzes and interprets data to form valid conclusions and to make recommendations.
  • 8.1.2 Integrates knowledge of biological, physical, and social sciences with knowledge of food and nutrition to make decisions related to nutrition care

Learning Objectives

  • Describe what and how early life exposures manipulate the development of the infant microbiome.
  • Characterize the microbial shifts that occur in obesity and allergic diseases.
  • Identify and explain current interventions targeting the gut microbiome in infancy to reduce disease risk.

Speakers

  • Stephanie Harshman
  • Maureen Leonard
  • Release Date: December 8, 2021
  • SKU FNCE21356